0
Your cart

Your cart is empty

Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology

Buy Now

Monoclonal Antibody Therapy of Human Cancer (Paperback, Softcover reprint of the original 1st ed. 1985) Loot Price: R2,921
Discovery Miles 29 210
Monoclonal Antibody Therapy of Human Cancer (Paperback, Softcover reprint of the original 1st ed. 1985): Kenneth A. Foon, Alton...

Monoclonal Antibody Therapy of Human Cancer (Paperback, Softcover reprint of the original 1st ed. 1985)

Kenneth A. Foon, Alton C. Morgan

Series: Developments in Oncology, 38

 (sign in to rate)
Loot Price R2,921 Discovery Miles 29 210 | Repayment Terms: R274 pm x 12*

Bookmark and Share

Expected to ship within 10 - 15 working days

KENNETH A. FOON and ALTON C. MORGAN, JR. Passive immunotherapy using heteroantisera for the treatment of cancer in animals and humans has been studied for over 50 years. Attempts have been made to treat animal tumors with sera from immunized syngeneic, allogeneic, or xenogeneic animals. A number of studies of passive immunotherapy using heterologous antisera in humans have also been performed. These studies have generally been attempted in patients with large tumor burdens, and as would be expected, results have been transient at best. A wide variety of solid tumors as well as leukemias and lym- phomas have been treated with antisera raised in sheep, horses, rabbits, and goats. Problems such as anaphylaxis, serum sick- ness, and severe cytopenias have been encountered with these antisera. There are a number of potential mechanisms by which unconju- gated antibodies might be cytotoxic to tumor cells. Antibodies bound to the cell surface membrane of tumor cells may lead to cell lysis by complement-dependent or antibody-dependent cellu- lar cytotoxicity. Circulating tumor cells bound by antibody may be more susceptible to phagocytosis by the reticuloendothelial system. Antibody bound to the cell surface membrane of tumor cells may enhance immunogenicity of the tumor cell leading to activation of the host's immune system.

General

Imprint: Springer-Verlag New York
Country of origin: United States
Series: Developments in Oncology, 38
Release date: February 2012
First published: 1985
Editors: Kenneth A. Foon • Alton C. Morgan
Dimensions: 235 x 155 x 10mm (L x W x T)
Format: Paperback
Pages: 162
Edition: Softcover reprint of the original 1st ed. 1985
ISBN-13: 978-1-4612-9642-3
Categories: Books > Medicine > Clinical & internal medicine > Diseases & disorders > Oncology > General
LSN: 1-4612-9642-0
Barcode: 9781461296423

Is the information for this product incomplete, wrong or inappropriate? Let us know about it.

Does this product have an incorrect or missing image? Send us a new image.

Is this product missing categories? Add more categories.

Review This Product

No reviews yet - be the first to create one!

Partners